ProCE Banner Activity

Understanding the Landscape of Immune Checkpoint Inhibitor Therapy in Early-Stage NSCLC: A Shared Decision-Making Resource for Clinicians and Patients

PDF

Download this patient-friendly PDF summarizing key points on using immune checkpoint inhibitors for early-stage NSCLC, from ongoing clinical trials to monitoring for and managing immune-related adverse events.

Released: September 22, 2021

Share

Faculty

Elizabeth Krueger

Elizabeth Krueger, NP

Nurse Practitioner
Thoracic Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Genentech, a member of the Roche Group

Faculty Disclosure

Primary Author

Elizabeth Krueger, NP

Nurse Practitioner
Thoracic Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Elizabeth Krueger, NP, has no relevant conflicts of interest to report.